Asante Capital congratulates Maguar Capital on the successful closing of Fund 2 at a hard cap of EUR 306 million

We are pleased to share that Maguar, a Munich-based investor group focused on B2B software companies in the DACH region, has closed Maguar 2 at EUR 306 million, significantly exceeding the EUR 250 million target.

Maguar 2 will see the firm continue its strategy from Fund 1: partnering with and investing in small-cap, profitable and growing software companies in the DACH region and helping them to become “regional and/or sector champions”. The fund close is nearly three times the size of the previous fund and attracted strong demand from existing and new investors. 

Asante served as exclusive global placement agent.

About Maguar

Maguar Capital Partners, based in Munich, Germany, was founded in 2019 by Arno Poschik, Gunther Thies and Matthias Ick. It focuses on B2B software investments in the small-cap segment with EBITDA typically in the range of EUR 1-8 million located in the DACH region. Maguar differentiates itself by the entrepreneurial background and long-term management experience of its team in the tech industry. The team has more than 35 years of CEO software experience and more than 20 years of private equity experience. Read Maguar’s press release here.

About Asante

Asante Capital Group is a leading independent private equity placement and advisory group. Founded in 2010, the firm has offices in London, New York City, Hong Kong, and Munich. The team of over 70 professionals has advised on over $80 billion of successful private capital raisings across the globe, raising capital from North American, European, Middle East and Asia-Pacific-based investors. Asante specializes in GP advisory and fundraising support across primary, direct and secondary investments.

Asante Capital congratulates partner HighLight Capital (HLC) on the final closing of its flagship HLC USD Fund IV at US$550 million

We are delighted to share that HighLight Capital (HLC), a private equity firm focusing on venture and growth investments across healthcare and consumer health sectors in China, held the final close of its flagship HLC USD Fund IV at US$550 million.

Asante Capital Group Celebrates 2023 Achievements, Extends Track Record of Successful Fundraises and Grows Global Team

As we enter 2024, Asante is pleased to announce another exceptional year, extending our track record of successful fundraising, strengthening our global presence and offerings, and facilitating expert discussions throughout 2023.

Asante Capital congratulates partner Abingworth on the final closing of its new Clinical Co-Development Co-Investment Fund at $356 million

We are delighted to share that Abingworth, a leading international life sciences investment group, part of global investment firm Carlyle (NASDAQ: CG), today announced the final closing of its new Clinical Co-Development Co-Investment Fund at $356 million.